FDA
approval
· 2021-04-20
FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Somerset Therapeutics, LLC)
Summary
The FDA approved a generic version of neostigmine methylsulfate through an original ANDA by Somerset Therapeutics, LLC. It is indicated for treatment of myasthe…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)